140 related articles for article (PubMed ID: 23962903)
1. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
[TBL] [Abstract][Full Text] [Related]
2. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
[TBL] [Abstract][Full Text] [Related]
5. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
Le Rhun E; Taillibert S; Zairi F; Kotecki N; Devos P; Mailliez A; Servent V; Vanlemmens L; Vennin P; Boulanger T; Baranzelli MC; André C; Marliot G; Cazin JL; Dubois F; Assaker R; Bonneterre J; Chamberlain MC
J Neurooncol; 2013 May; 113(1):83-92. PubMed ID: 23456656
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.
Bokstein F; Lossos A; Siegal T
Cancer; 1998 May; 82(9):1756-63. PubMed ID: 9576299
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal metastases--treatment results in 98 consecutive patients.
Pfeffer MR; Wygoda M; Siegal T
Isr J Med Sci; 1988; 24(9-10):611-8. PubMed ID: 3144516
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal thiotepa: reappraisal of an established therapy.
Fisher PG; Kadan-Lottick NS; Korones DN
J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
[TBL] [Abstract][Full Text] [Related]
10. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
Zhou X; Wang X; Song Q; Yang H; Zhu X; Yu J; Song G; Di L; Ren J; Shao H; Lyerly HK
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):914-22. PubMed ID: 26396136
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
12. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
13. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
15. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
16. Therapy of leptomeningeal metastasis in solid tumors.
Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
[TBL] [Abstract][Full Text] [Related]
17. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
18. Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Bitran JD; Samuels B; Klein L; Hanauer S; Johnson L; Martinec J; Harris E; Kempler J; White W
Bone Marrow Transplant; 1996 Feb; 17(2):157-62. PubMed ID: 8640160
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
20. Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series.
Chahal J; Stopeck A; Clarke K; Livingston RB; Chalasani P
Neurol Sci; 2015 Sep; 36(9):1691-3. PubMed ID: 25990104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
